Back

Insights into the reporting of major adverse cardiovascular events in coronary artery disease trials

30 August 2024 (11:00 - 11:40)
Organised by: Logo
Congress Presentation Part of: Frontiers in acute coronary syndromes: diagnosis, prognosis, and intervention Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Vickram Vijay Anand

Singapore (Singapore)

4 More presentations in this session

Presentation thumbnail
Incremental role of Cardio-Ankle Vascular Index in predicting ischemic threshold in patients with suspected coronary artery disease
Doctor A. Tunhasiriwet (Bangkok, TH)
Abstract Slides
Presentation thumbnail
The clinical characteristics and prognosis of patients with acute ST-segment elevation myocardial infarction complicated with impaired activity daily living
Professor K. Chen (Tianjin, CN)
Abstract Slides
Presentation thumbnail
Comparative characteristics and invasive management in patients with non-ST elevation acute coronary syndromes in two high-volume hospitals from Romania and Germany
Assistant Professor A. Cotoban (Bucharest, RO)
Abstract Slides
Presentation thumbnail
Clinical significance of 12-lead electrocardiogram QRS scores on admission in ST-segment elevation myocardial infarction
Assistant Professor K. Tsutsumi (Yokohama, JP)
Abstract Slides

Access the full session

Session thumbnail
Frontiers in acute coronary syndromes: diagnosis, prognosis, and intervention

The Event

Event poster

ESC Congress 2024

30 August 2024 11:00 CET
You may be interested in
thumbnail
Congress Presentation
Effect of statins on MACE in patients with coronary artery spasm: a meta-analysis
thumbnail
Congress Presentation
Percutaneous coronary intervention and risk of major adverse cardiovascular events in patients with coronary artery ectasia and acute coronary syndrome
thumbnail
Congress Presentation
Characteristics, adverse event reporting and completeness of intervention description in short-term mechanical circulatory support trials: an observational study

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources